Operating Expenses - Novogene Co Ltd (SSE:688315) - Alpha Spread

Novogene Co Ltd
SSE:688315

Watchlist Manager
Novogene Co Ltd Logo
Novogene Co Ltd
SSE:688315
Watchlist
Price: 9.45 CNY -3.67% Market Closed
Market Cap: 3.9B CNY
Have any thoughts about
Novogene Co Ltd?
Write Note

Novogene Co Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Novogene Co Ltd
Operating Expenses Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Novogene Co Ltd
SSE:688315
Operating Expenses
-ÂĄ668.7m
CAGR 3-Years
-13%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Operating Expenses
-ÂĄ4.8B
CAGR 3-Years
-13%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Operating Expenses
-ÂĄ2.3B
CAGR 3-Years
-34%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Operating Expenses
-ÂĄ2.9B
CAGR 3-Years
-37%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Operating Expenses
-ÂĄ1.2B
CAGR 3-Years
-17%
CAGR 5-Years
-17%
CAGR 10-Years
-30%
Genscript Biotech Corp
HKEX:1548
Operating Expenses
-$936.5m
CAGR 3-Years
-18%
CAGR 5-Years
-35%
CAGR 10-Years
N/A

See Also

What is Novogene Co Ltd's Operating Expenses?
Operating Expenses
-668.7m CNY

Based on the financial report for Dec 31, 2023, Novogene Co Ltd's Operating Expenses amounts to -668.7m CNY.

What is Novogene Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-14%

Over the last year, the Operating Expenses growth was -5%. The average annual Operating Expenses growth rates for Novogene Co Ltd have been -13% over the past three years , -14% over the past five years .

Back to Top